title: Respiratory care year in review 2012: Asthma and sleep-disordered breathing.
abstract: Asthma has long been recognized as a common respiratory disease, and the recognition of sleep-disordered breathing is becoming more prevalent. Patients with these disorders are commonly seen by clinicians caring for patients with respiratory disease. There is also much academic interest in asthma and sleep-disordered breathing. The purpose of this paper is to review the recent literature related to asthma and sleep-disordered breathing in a manner that is most likely to have interest to the readers of Respiratory Care.
authors.affiliation: American Association for Respiratory Care, Irving, Texas, USA.
authors.forename: Timothy R
authors.initials: TR
authors.lastname: Myers
authors.forename: Suzanne M
authors.initials: SM
authors.lastname: Bollig
authors.forename: Dean R
authors.initials: DR
authors.lastname: Hess
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy / Q000503:physiopathology* / Q000517:prevention & control; D002318:Cardiovascular Diseases / Q000453:epidemiology; D003920:Diabetes Mellitus / Q000453:epidemiology*; D006801:Humans; D015994:Incidence; D008991:Monitoring, Physiologic; D010353:Patient Education as Topic; D012129:Respiratory Function Tests; D012891:Sleep Apnea Syndromes / Q000175:diagnosis / Q000453:epidemiology* / Q000401:mortality / Q000503:physiopathology
chemical_list: D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D018927:Anti-Asthmatic Agents